Reference SummaryAndrechek ER, Proc Natl Acad Sci U S A 2009 Sep 22;106(38):16387-92

Title

Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential.

Authors

Andrechek ER; Cardiff RD; Chang JT; Gatza ML; Acharya CR; Potti A; Nevins JR

Journal

Proc Natl Acad Sci U S A

Volume

106

Issue

38

Year

2009

Pages

16387-92

Abstract

Human cancers result from a complex series of genetic alterations, resulting in heterogeneous disease states. Dissecting this heterogeneity is critical for understanding underlying mechanisms and providing opportunities for therapeutics matching the complexity. Mouse models of cancer have generally been used to reduce this complexity and focus on the role of single genes. Nevertheless, our analysis of tumors arising in the MMTV-Myc model of mammary carcinogenesis reveals substantial heterogeneity, seen in both histological and expression phenotypes. One contribution to this heterogeneity is the substantial frequency of activating Ras mutations. Additionally, we show that these Myc-induced mammary tumors exhibit even greater heterogeneity, revealed by distinct histological subtypes as well as distinct patterns of gene expression, than many other mouse models of tumorigenesis. Two of the major histological subtypes are characterized by differential patterns of cellular signaling pathways, including beta-catenin and Stat3 activities. We also demonstrate that one of the MMTV-Myc mammary tumor subgroups exhibits metastatic capacity and that the signature derived from the subgroup can predict metastatic potential of human breast cancer. Together, these data reveal that a combination of histological and genomic analyses can uncover substantial heterogeneity in mammary tumor formation and therefore highlight aspects of tumor phenotype not evident in the population as a whole.

Links

J:153233 – MGI References
19805309 – National Library of Medicine/PubMed

Strain Notes

Strain Note
FVB/N-Tg(MMTV-Myc*T58A)TA#Jrn The founder line of these mice was not specified (either "TA14", "TA41", or a pool from both).
FVB/N-Tg(MMTV-Myc)WT#Jrn The founder line of these mice was not specified (either "WT13", "WT21", or a pool from both).

Models

Strain Model Name Treatment Agent(s) Organ Affected Frequency Model Details
FVB/N-Tg(MMTV-Myc)WT#Jrn Mammary gland adenocarcinoma Mammary gland

observed

FVB/N-Tg(MMTV-Myc*T58A)TA#Jrn Mammary gland adenocarcinoma Mammary gland

observed

BALB/cJ-Brca1tm1Bhk/+ Trp53tm1Tyj/+ Mammary gland carcinoma
  • gamma-radiation
Mammary gland

observed

BALB/cJ-Trp53tm1Tyj/+ Mammary gland carcinoma
  • gamma-radiation
Mammary gland

observed

C.Cg-Tg(WAPT121)66Tvd Mammary gland carcinoma Mammary gland

observed

B6D2-Tg(WAPT121)66Tvd Mammary gland carcinoma Mammary gland

observed

C57BL/6J-Tg(WapTAg)1Knw Mammary gland carcinoma Mammary gland

observed

C57BL/6-Brca1tm2Cxd Trp53tm1Brd/+ Tg(MMTV-cre)4Mam Mammary gland carcinoma Mammary gland

observed

FVB Mammary gland carcinoma
  • medroxyprogesterone actetate (MPA)
  • dimethylbenzanthracene (DMBA)
Mammary gland

observed

FVB-Tg(C3-1-TAg)cJeg Mammary gland carcinoma Mammary gland

observed

FVB-Tg(MMTVneu)202Mul Mammary gland carcinoma Mammary gland

observed

FVB-Tg(MMTV-PyVT)634Mul Mammary gland carcinoma Mammary gland

observed

FVB.Cg-Tg(Wnt1)1Hev Mammary gland carcinoma Mammary gland

observed

FVB-Tg(WapNotch4)10Rnc Mammary gland carcinoma Mammary gland

observed

FVB.Cg-Tg(WapMyc)212Bri Mammary gland carcinoma Mammary gland

observed

BALB/cJ Mammary gland normal tissue (control) Mammary gland

not applicable

FVB/NJ Mammary gland normal tissue (control) Mammary gland

not applicable

FVB/N-Tg(MMTV-Myc)WT#Jrn Mammary gland tumor Mammary gland

observed

FVB/N-Tg(MMTV-Myc*T58A)TA#Jrn Mammary gland tumor Mammary gland

observed

FVB/N-Tg(MMTV-Erbb2*)NDL2-5Mul Mammary gland tumor Mammary gland

observed

FVB/N-Tg(MMTV-Myc)WT#Jrn Mammary gland tumor - EMT Mammary gland

observed

FVB/N-Tg(MMTV-Myc*T58A)TA#Jrn Mammary gland tumor - EMT Mammary gland

observed

FVB/N-Tg(MMTV-Myc)WT#Jrn Mammary gland tumor - microacinar Mammary gland

observed

FVB/N-Tg(MMTV-Myc*T58A)TA#Jrn Mammary gland tumor - microacinar Mammary gland

observed

FVB/N-Tg(MMTV-Myc)WT#Jrn Mammary gland tumor - mixed Mammary gland

observed

FVB/N-Tg(MMTV-Myc*T58A)TA#Jrn Mammary gland tumor - mixed Mammary gland

observed

FVB/N-Tg(MMTV-Myc)WT#Jrn Mammary gland tumor - papillary Mammary gland

observed

FVB/N-Tg(MMTV-Myc*T58A)TA#Jrn Mammary gland tumor - papillary Mammary gland

observed

FVB/N-Tg(MMTV-Myc)WT#Jrn Mammary gland tumor - solid Mammary gland

observed

FVB/N-Tg(MMTV-Myc*T58A)TA#Jrn Mammary gland tumor - solid Mammary gland

observed

FVB/N-Tg(MMTV-Myc)WT#Jrn Mammary gland tumor - squamous Mammary gland

observed

FVB/N-Tg(MMTV-Myc*T58A)TA#Jrn Mammary gland tumor - squamous Mammary gland

observed